[1] 吴晓燕,苗琳,郑蕊,等.心肌缺血再灌注损伤的研究进展[J].中国临床药理学,2016,32(11):1043-1045,1056.
[2] FRIEDENSTEIN AJ, PETRAKOVA KV, KUROLESOVA AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6(2):230-247.
[3] 符武岛,曾敏,陈娟,等.表没食子儿茶素没食子酸酯通过抑制心肌细胞凋亡缓解心肌缺血再灌注损伤的机制研究[J].中国药房, 2019,30(16):2187-2192.
[4] AHMED S, AHMED N, RUNGATSCHER A, et al. Cocoa Flavonoids Reduce Inflammation and Oxidative Stress in a Myocardial Ischemia-Reperfusion Experimental Model. Antioxidants (Basel). 2020;9(2):167.
[5] 许毛,刘娜,苏燕胜.纤维蛋白原与心肌缺血再灌注损伤患者炎症反应的相关性分析[J].西安交通大学学报(医学版),2018,39(5): 698-702.
[6] AL-SALAM S, HASHMI S. Myocardial Ischemia Reperfusion Injury: Apoptotic, Inflammatory and Oxidative Stress Role of Galectin-3. Cell Physiol Biochem. 2018;50(3):1123-1139.
[7] SHIN EY, WANG L, ZEMSKOVA M, et al. Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury. J Am Heart Assoc. 2018;7(2):e006949.
[8] HONG HS, KIM S, LEE S, et al. Substance-P Prevents Cardiac Ischemia-Reperfusion Injury by Modulating Stem Cell Mobilization and Causing Early Suppression of Injury-Mediated Inflammation. Cell Physiol Biochem. 2019;52(1):40-56.
[9] ADINOLFI E, GIULIANI AL, DE MARCHI E, et al. The P2X7 receptor: A main player in inflammation. Biochem Pharmacol. 2018;151:234-244.
[10] WANG J, CHEN Z, DAI Q, et al. Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury. Basic Res Cardiol. 2020;115(4):40.
[11] KORKMAZ-ICÖZ S, LI S, HÜTTNER R, et al. Hypothermic perfusion of donor heart with a preservation solution supplemented by mesenchymal stem cells. J Heart Lung Transplant. 2019;38(3):315-326.
[12] 张泽宇,苗迎春,张威,等.脂肪间充质干细胞移植对大鼠心肌缺血再灌注后炎症反应及心脏功能的影响[J].解放军医学院学报, 2016,37(4):381-385.
[13] 陈士金,史钰芳,张博,等.脐带间充质干细胞移植对急性心肌缺血-再灌注损伤大鼠VEGF及MCP-1的影响[J].国际生物医学工程杂志,2017,40(6):453-456.
[14] 梁贵友,余丽梅,巫宏坤,等.一种人羊膜间充质干细胞的应用:中国, CN201610235663.0[P].2016-07-20.
[15] BOND TA, KARHUNEN V, WIELSCHER M, et al. Exploring the role of genetic confounding in the association between maternal and offspring body mass index: evidence from three birth cohorts. Int J Epidemiol. 2020;49(1):233-243.
[16] ZHANG Z, TIAN H, YANG C, et al. Mesenchymal Stem Cells Promote the Resolution of Cardiac Inflammation After Ischemia Reperfusion Via Enhancing Efferocytosis of Neutrophils. J Am Heart Assoc. 2020; 9(5):e014397.
[17] WEI Z, QIAO S, ZHAO J, et al. miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury. Life Sci. 2019; 232:116632.
[18] PRABHU SD, FRANGOGIANNIS NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016;119(1):91-112.
[19] ZHENG G, HUANG R, QIU G, et al. Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis. Cell Tissue Res. 2018;374(1):1-15.
[20] 何尤夫,石蓓.干细胞源外泌体治疗缺血性心脏病的近况[J].临床与病理杂志,2017,37(2):422-428.
[21] LIU L, JIN X, HU CF, et al. Exosomes Derived from Mesenchymal Stem Cells Rescue Myocardial Ischaemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy Via AMPK and Akt Pathways. Cell Physiol Biochem. 2017;43(1):52-68.
[22] ZHANG N, SONG Y, HUANG Z, et al. Monocyte mimics improve mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI/RI model. Biomaterials. 2020;255:120168.
[23] GONG XH, LIU H, WANG SJ, et al. Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction. J Cell Physiol. 2019;234(8): 13878-13893.
[24] JU C, SHEN Y, MA G, et al. Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium. J Cardiovasc Transl Res. 2018;11(5):420-428.
[25] LU M, XU Y, WANG M, et al. MicroRNA-23 inhibition protects the ischemia/reperfusion injury via inducing the differentiation of bone marrow mesenchymal stem cells into cardiomyocytes. Int J Clin Exp Pathol. 2019;12(3):1060-1069.
[26] 孙理华,王娟,张岳,等.间充质干细胞来源的外泌体通过microRNA-21-5p调节心脏自噬并影响心肌缺血大鼠的心脏功能[J].中国比较医学杂志,2020,30(5):88-96.
[27] CHENG J, ZHANG P, JIANG H. Let-7b-mediated pro-survival of transplanted mesenchymal stem cells for cardiac regeneration. Stem Cell Res Ther. 2015;6:216.
[28] ULLAH I, SUBBARAO RB, RHO GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.
[29] SUN XH, WANG X, ZHANG Y, et al. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway. Thromb Res. 2019;177:23-32.
[30] ZHOU Y, CHEN P, LIU Q, et al. Hepatoma-Derived Growth Factor Secreted from Mesenchymal Stem Cells Reduces Myocardial Ischemia-Reperfusion Injury. Stem Cells Int. 2017;2017:1096980.
[31] CHEN Q, LIU Y, DING X, et al. Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7. Mol Cell Biochem. 2020;465(1-2):103-114.
[32] OU H, TENG H, QIN Y, et al. Extracellular vesicles derived from microRNA-150-5p-overexpressing mesenchymal stem cells protect rat hearts against ischemia/reperfusion. Aging (Albany NY). 2020; 12(13):12669-12683.
[33] ZHANG B, WU X, ZHANG X, et al. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway. Stem Cells Transl Med. 2015;4(5):513-522.
[34] MA J, ZHAO Y, SUN L, et al. Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D. Stem Cells Transl Med. 2017;6(1):51-59.
[35] ROŞCA AM, ŢUŢUIANU R, TITORENCU ID. Mesenchymal stromal cells derived exosomes as tools for chronic wound healing therapy. Rom J Morphol Embryol. 2018;59(3):655-662.
[36] 刘卒,韩燊,李亚雄,等.不同干细胞来源外泌体在心血管疾病治疗中的应用、作用及问题[J].中国组织工程研究,2020,24(19): 3063-3070.
[37] SUN L, XU R, SUN X, et al. Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell. Cytotherapy. 2016;18(3):413-422.
[38] PITT JM, KROEMER G, ZITVOGEL L. Extracellular vesicles: masters of intercellular communication and potential clinical interventions. J Clin Invest. 2016;126(4):1139-1143.
[39] GNECCHI M, DANIELI P, MALPASSO G, et al. Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair. Methods Mol Biol. 2016; 1416:123-146.
[40] XU H, DONG H, ZHAO M. Effects of human umbilical cord mesenchymal stem cells on vascular endothelial growth factor and IL-6 expression in tissue of AMI rats. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017; 29(6):511-514.
[41] GU W, HONG X, POTTER C, et al. Mesenchymal stem cells and vascular regeneration. Microcirculation. 2017;24(1):e12324.
[42] BARILE L, MOCCETTI T, MARBÁN E, et al. Roles of exosomes in cardioprotection. Eur Heart J. 2017;38(18):1372-1379.
[43] MONTANARI S, DAYAN V, YANNARELLI G, et al. Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model. J Heart Lung Transplant. 2015;34(11): 1481-1488.
[44] 张红玉.舒芬太尼联合脐血间充质干细胞移植对梗死心肌的保护作用[J].中国组织工程研究,2016,20(41):6164-6170.
[45] CIUFFREDA MC, MALPASSO G, CHOKOZA C, et al. Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. Acta Biomater. 2018;70:71-83.
[46] LI X, XIE X, YU Z, et al. Bone marrow mesenchymal stem cells-derived conditioned medium protects cardiomyocytes from hypoxia/reoxygenation-induced injury through Notch2/mTOR/autophagy signaling. J Cell Physiol. 2019;234(10):18906-18916.
[47] 禹丽,许兰莹,黄启星,等.硫氧还蛋白1基因修饰骨髓间充质干细胞对心肌梗死大鼠血管生成及心功能恢复的研究[J].临床和实验医学杂,2019,18(17):1808-1811.
[48] 王燕.Akt基因修饰羊水间充质干细胞移植对兔心肌缺血再灌注损伤的作用研究[D].上海:上海交通大学,2016. |